UroGen Pharma Ltd.
URGN
22 insider filings · Latest: Oct 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2025 | Sep 9 1:51 PM | Schoenberg Mark | Proposed Sale | 871 | $18.88 | $16.4K | — | View → |
| Sep 8, 2025 | Sep 9 11:59 AM | Smith Jason Drew | Proposed Sale | 1,520 | $18.88 | $28.7K | — | View → |
| Jul 28, 2025 | Jul 29 11:29 AM | Schoenberg Mark | Proposed Sale | 5,149 | $18.95 | $97.6K | — | View → |
| Jul 28, 2025 | Jul 29 11:23 AM | Smith Jason Drew | Proposed Sale | 7,522 | $18.95 | $142.5K | — | View → |
| Jun 9, 2025 | Jun 10 1:27 PM | Schoenberg Mark | Proposed Sale | 5,162 | $7.37 | $38.0K | — | View → |
| Sep 9, 2024 | Sep 10 11:16 AM | Schoenberg Mark | Proposed Sale | 859 | $13.23 | $11.4K | — | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | Oct 9 4:57 PM | Chris DegnanChief Financial Officer | Option Exercise | 4,483 | — | 4,484(D) | View → |
| Sep 7, 2026 | Sep 9 6:37 PM | Mark SchoenbergChief Medical Officer | Option Exercise | 1,667 | — | 0(D) | View → |
| Sep 7, 2026 | Sep 9 6:35 PM | Jason Drew SmithGeneral Counsel | Option Exercise | 3,334 | — | 0(D) | View → |
| Aug 26, 2026 | Aug 28 8:01 PM | James A. Robinson Jr.Director | Option Exercise | 2,000 | — | 0(D) | View → |
| Jun 22, 2026 | Jun 24 2:03 PM | Daniel George WildmanDirector | Grant/Award | 18,000 | $34.99 | 8,000(D) | View → |
| Jun 22, 2026 | Jun 24 2:02 PM | James A. Robinson Jr.Director | Grant/Award | 18,000 | $34.99 | 8,000(D) | View → |
| Jun 22, 2026 | Jun 24 2:01 PM | Stuart HoldenDirector | Grant/Award | 20,000 | $34.99 | 20,000(D) | View → |
| Jun 22, 2026 | Jun 24 2:00 PM | Cynthia M ButittaDirector | Grant/Award | 18,000 | $34.99 | 8,000(D) | View → |
| Jun 22, 2026 | Jun 24 1:58 PM | Leana WenDirector | Grant/Award | 18,000 | $34.99 | 8,000(D) | View → |
| Jun 22, 2026 | Jun 24 1:57 PM | Arie BelldegrunDirector | Grant/Award | 20,000 | $34.99 | 20,000(D) | View → |
| Jun 8, 2026 | Jun 9 5:59 PM | Mark SchoenbergChief Medical Officer | Option Exercise | 10,000 | — | 0(D) | View → |
| May 26, 2026 | May 27 12:04 PM | James A. Robinson Jr.Director | Option Exercise | 2,000 | — | 2,000(D) | View → |
| Feb 26, 2025 | Feb 27 9:44 PM | James A. Robinson Jr.Director | Option Exercise | 2,000 | — | 4,000(D) | View → |
| Jan 31, 2026 | Feb 19 3:46 PM | Elizabeth A. BarrettChief Executive Officer | Grant/Award | 153,195 | — | 153,195(D) | View → |
| Jan 31, 2026 | Feb 11 7:54 PM | Jason Drew SmithGeneral Counsel | Grant/Award | 32,609 | — | 32,609(D) | View → |
| Jan 31, 2026 | Feb 11 7:54 PM | Jason Drew SmithGeneral Counsel | Option Exercise | 15,500 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 10:18 PM | Mark SchoenbergChief Medical Officer | Grant/Award | 20,000 | — | 20,000(D) | View → |
| Jan 31, 2026 | Feb 3 10:18 PM | Mark SchoenbergChief Medical Officer | Option Exercise | 13,333 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 10:16 PM | Chris DegnanChief Financial Officer | Grant/Award | 32,609 | — | 32,609(D) | View → |